Randomised phase II trial of cediranib (AZD2171) vs. placebo in addition to cisplatin/gemcitabine chemotherapy for patients with advanced biliary tract cancers.
Phase of Trial: Phase II
Latest Information Update: 28 Jul 2016
At a glance
- Drugs Cediranib (Primary) ; Cisplatin; Gemcitabine
- Indications Biliary cancer; Gallbladder cancer
- Focus Therapeutic Use
- Acronyms ABC-03
- 10 Jun 2017 Biomarkers information updated
- 10 Jul 2015 Results published in the Lancet Oncology.
- 02 Jun 2015 Results assessing plasma biomarkers presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History